[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

MXPA02000003A - Compuestos triciclicos que tienen una union espiro. - Google Patents

Compuestos triciclicos que tienen una union espiro.

Info

Publication number
MXPA02000003A
MXPA02000003A MXPA02000003A MXPA02000003A MXPA02000003A MX PA02000003 A MXPA02000003 A MX PA02000003A MX PA02000003 A MXPA02000003 A MX PA02000003A MX PA02000003 A MXPA02000003 A MX PA02000003A MX PA02000003 A MXPA02000003 A MX PA02000003A
Authority
MX
Mexico
Prior art keywords
spiro union
tricyclic compounds
useful
relates
inhibitor
Prior art date
Application number
MXPA02000003A
Other languages
English (en)
Inventor
Hidemitsu Nishida
Original Assignee
Mochida Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mochida Pharm Co Ltd filed Critical Mochida Pharm Co Ltd
Publication of MXPA02000003A publication Critical patent/MXPA02000003A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/20—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96433—Serine endopeptidases (3.4.21)
    • G01N2333/96441—Serine endopeptidases (3.4.21) with definite EC number
    • G01N2333/96444—Factor X (3.4.21.6)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Prostheses (AREA)
  • External Artificial Organs (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
MXPA02000003A 1999-06-30 2000-06-30 Compuestos triciclicos que tienen una union espiro. MXPA02000003A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP22288399 1999-06-30
PCT/JP2000/004374 WO2001002397A1 (fr) 1999-06-30 2000-06-30 Composes tricycliques presentant une jonction spiro

Publications (1)

Publication Number Publication Date
MXPA02000003A true MXPA02000003A (es) 2003-07-21

Family

ID=16789385

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02000003A MXPA02000003A (es) 1999-06-30 2000-06-30 Compuestos triciclicos que tienen una union espiro.

Country Status (21)

Country Link
EP (1) EP1191028B1 (es)
JP (1) JP4890707B2 (es)
KR (1) KR20020015061A (es)
CN (1) CN1371375A (es)
AT (1) ATE281457T1 (es)
AU (1) AU774397B2 (es)
BR (1) BR0012093A (es)
CA (1) CA2380852C (es)
CZ (1) CZ20014696A3 (es)
DE (1) DE60015541T2 (es)
HK (1) HK1049157A1 (es)
HU (1) HUP0202188A3 (es)
IL (1) IL147348A0 (es)
MX (1) MXPA02000003A (es)
NO (1) NO20016402L (es)
NZ (1) NZ516363A (es)
PL (1) PL352862A1 (es)
SK (1) SK19292001A3 (es)
TR (1) TR200103853T2 (es)
WO (1) WO2001002397A1 (es)
ZA (1) ZA200110558B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001269531A1 (en) * 2000-07-17 2002-01-30 Takeda Chemical Industries Ltd. Sulfone derivatives, process for their production and use thereof
EP1346994A4 (en) * 2000-12-28 2005-01-19 Mochida Pharm Co Ltd INHIBITORS OF THE CHOLESTEROL BIOSYNTHESIS CONTAINING TRICYCLIC SPIRO COMPOUNDS AS AN ACTIVE SUBSTANCE
DK1569912T3 (en) 2002-12-03 2015-06-29 Pharmacyclics Inc 2- (2-hydroxybiphenyl-3-yl) -1h-benzoimidazole-5-carboxamidine derivatives as factor VIIa inhibitors.
TWI396686B (zh) 2004-05-21 2013-05-21 Takeda Pharmaceutical 環狀醯胺衍生物、以及其製品和用法
WO2006006490A1 (ja) * 2004-07-08 2006-01-19 Ono Pharmaceutical Co., Ltd. スピロ化合物
JPWO2006106804A1 (ja) 2005-03-31 2008-09-11 持田製薬株式会社 環内窒素原子にアシル基が結合した三環系スピロ化合物
JPWO2007136085A1 (ja) 2006-05-23 2009-10-01 持田製薬株式会社 スピロ四環系化合物
US7739434B2 (en) 2008-01-11 2010-06-15 International Business Machines Corporation Performing a configuration virtual topology change and instruction therefore

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE136032T1 (de) * 1987-07-20 1996-04-15 Duphar Int Res 8,9-anellierte 1,2,3,4-tetrahydro-beta-carbolin- derivate
US5292747A (en) * 1990-08-07 1994-03-08 Hoffman-La Roche Inc. Substituted pyrroles

Also Published As

Publication number Publication date
SK19292001A3 (sk) 2002-06-04
PL352862A1 (en) 2003-09-08
WO2001002397A1 (fr) 2001-01-11
CA2380852A1 (en) 2001-01-11
DE60015541D1 (de) 2004-12-09
KR20020015061A (ko) 2002-02-27
CZ20014696A3 (cs) 2002-05-15
AU5572000A (en) 2001-01-22
TR200103853T2 (tr) 2002-11-21
HUP0202188A2 (en) 2002-10-28
NZ516363A (en) 2004-05-28
NO20016402L (no) 2002-02-27
BR0012093A (pt) 2002-07-16
AU774397B2 (en) 2004-06-24
CA2380852C (en) 2009-10-20
HK1049157A1 (zh) 2003-05-02
WO2001002397A9 (fr) 2001-04-05
ZA200110558B (en) 2002-09-12
EP1191028B1 (en) 2004-11-03
CN1371375A (zh) 2002-09-25
EP1191028A1 (en) 2002-03-27
IL147348A0 (en) 2002-08-14
JP4890707B2 (ja) 2012-03-07
DE60015541T2 (de) 2005-12-08
ATE281457T1 (de) 2004-11-15
HUP0202188A3 (en) 2004-04-28
NO20016402D0 (no) 2001-12-28
EP1191028A4 (en) 2002-10-23

Similar Documents

Publication Publication Date Title
ATE260255T1 (de) 5-oxo-pyrrolidine-2-carbonsäure- hydroxamidderivate
DE69615674D1 (de) Cyclobutan-derivate als inhibitoren der squalen-synthase und der protein farnesyltransferase
EA200800485A1 (ru) Макроциклические ингибиторы вируса гепатита с
EP1591446A4 (en) THIENOPYRIMIDINE COMPOUNDS AND THEIR USE
ATE540928T1 (de) Isochinolinverbindungen und ihre medizinische verwendung
WO2000061568A8 (de) Mit zuckerresten substituierte 1,4-benzothiazepin-1,1-dioxidderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
ATE453393T1 (de) Verwendung von pyridylamiden als angiogenesehemmer
AU2001232287A1 (en) Novel pyrazine derivatives or salts thereof, pharmaceutical compositions containing the derivatives or the salts and intermediates for the preparation of both
BR0314688A (pt) Novos derivados de piperidina para utilização no tratamento de estados de doença mediados pela quimiocina
DE60226764D1 (de) Substituierte heteroarylalkansäure und ihre verwendung als inhibitoren der aldose reductase
MY139461A (en) Condensed furan compounds
AU6518998A (en) Morphinane derivatives and medicinal use thereof
WO2005005389A3 (en) Malonamide derivatives
IL147348A0 (en) Tricyclic compounds having spiro union
DE60122555D1 (de) Spiroverbindungen und diese als wirkstoff enthaltende adhäsionsmolekülinhibitoren
WO2006012395A3 (en) Peptidase inhibitors
WO2003082192A3 (en) Certain pharmaceutically useful substituted aminoalkyl heterocycles
WO2002026732A1 (fr) Derive de benzodiazepine
HK1064673A1 (en) Fused-polycyclic compounds
AU2002339158A1 (en) 2-(3-sulfonylamino-2-oxopyrrolidin-1-yl)propanamides as factor xa inhibitors
ATE275558T1 (de) 4-arylpiperidinderivate zur behandlung von pruritus
TH80960B (th) ซัลฟานิลแทนที่ฟีนิลเมทธาโนนซ์
TH80960A (th) ซัลฟานิลแทนที่ฟีนิลเมทธาโนนซ์